Tissue engineering—optimizing on the human body’s ability to heal itself in order to rebuild muscle and bone—is a major 3D printing application, as it can be used to fabricate the scaffolds that are necessary to support cell regrowth. However, it’s not a magic technology, and there are still some hurdles to overcome, one of which is the fact that making very small, very complex scaffolds is extremely difficult to do. But a team of researchers from Australia’s RMIT University teamed up with clinicians at St Vincent’s Hospital Melbourne to create tiny, intricate bioscaffolds the size of fingernails for tissue engineering purposes using glue and 3D printed molds…not seen quite as often in the medical field.
The team published a study, “Printing between the Lines: Intricate Biomaterial Structures Fabricated via Negative Embodied Sacrificial Template 3D (NEST3D) Printing,” about their research, which took place at the hospital’s bioengineering research, education, and training hub [email protected]. This interdisciplinary collaboration really shows what kinds of innovations are possible when people from different fields put their heads together to solve a problem.
“A common problem faced by clinicians is the inability to access technological experimental solutions for the problems they face daily. While a clinician is the best professional to recognize a problem and think about potential solutions, biomedical engineers can turn that idea into reality,” explained study co-author Associate Professor Claudia Di Bella, an orthopedic surgeon at St. Vincent’s Hospital Melbourne.
“Learning how to speak a common language across engineering and medicine is often an initial barrier, but once this is overcome, the possibilities are endless.”
Standard extrusion-based 3D printers would typically not be able to handle this type of print job, so the team flipped the technology on its head. The teeny molds the researchers printed featured complex patterned cavities, which were then filled with biocompatible materials before the molds were dissolved away. According to lead researcher Dr. Cathal O’Connell, a Vice-Chancellor’s Postdoctoral Fellow at RMIT, the team’s biofabrication method used AM technology that’s easily available, which made the process scalable and cost-effective.
Dr. O’Connell explained, “The shapes you can make with a standard 3D printer are constrained by the size of the printing nozzle – the opening needs to be big enough to let material through and ultimately that influences how small you can print.
“But the gaps in between the printed material can be way smaller, and far more intricate.
“By flipping our thinking, we essentially draw the structure we want in the empty space inside our 3D printed mold. This allows us to create the tiny, complex microstructures where cells will flourish.”
The researchers use PVA glue as the basis for the 3D printed mold in their new method, which they have named Negative Embodied Sacrificial Template 3D, or NEST3D, printing. After the biocompatible material injected into the mold has set, the structure is put in water in order to dissolve the glue, which just leaves the bioscaffold behind.
“Extrusion printing techniques are widely used across tissue engineering and related fields for producing 3D structures from biocompatible thermoplastics, however the achievable structural complexity and porosity can be limited by the nozzle-based, layer-by-layer deposition process. Here, how this limitation can be overcome through a new technique termed Negative Embodied Sacrificial Template 3D printing is illustrated,” the researchers explained in their study. “It is demonstrated how the negative pattern within a 3D printed object can easily describe geometries that are extremely challenging to extrusion print directly with biomaterials, and at high resolution. Negative patterns in a water-soluble sacrificial template can be “developed” by casting in a secondary material and dissolving the template, creating exquisitely complex 3D structures including hyper-branched dendritic structures and open lattices with stiffnesses tuneable over 3 orders of magnitude. The technique is amenable to a plethora of materials from biodegradable thermoplastics (such as polycaprolactone) to resins (including acrylic and epoxy), silicones (including the Sylgard 184 polydimethylsiloxane formulation), ceramics (including hydroxyapatite composites), hydrogels (including agarose and gelatin methacryloyl), low-melt temperature metal alloys and others. Using an unmodified, consumer-grade printer, NEST3D printing achieves high resolution, intricate biomaterial structures with potential applications in biomedical implants and tissue engineering scaffolds.”
As the study’s first author, PhD researcher Stephanie Doyle, explains, NEST3D printing makes it possible to test different combinations of materials in order to select the most effective ones for cell growth.
“The advantage of our advanced injection molding technique is its versatility. We can produce dozens of trial bioscaffolds in a range of materials – from biodegradable polymers to hydrogels, silicones and ceramics – without the need for rigorous optimization or specialist equipment,” Doyle said.
“We’re able to produce 3D structures that can be just 200 microns across, the width of 4 human hairs, and with complexity that rivals that achievable by light-based fabrication techniques.
“It could be a massive accelerator for biofabrication and tissue engineering research.”
Speaking of materials, Dr. O’Connell noted that while other AM methods are able to create smaller, more intricate biostructures, only specially tailored materials, modified with special chemistry or tuned with specific additives, can be used. The beauty of this process is its materials flexibility.
“Importantly, our technique is versatile enough to use medical grade materials off-the-shelf. It’s extraordinary to create such complex shapes using a basic high school grade 3D printer. That really lowers the bar for entry into the field and brings us a significant step closer to making tissue engineering a medical reality,” Dr. O’Connell said.
Another benefit of NEST3D printing is its ability to create bioscaffolds that work with both cartilage and bone, which could be a major boon for the orthopedics field.
“Our new method is so precise we’re creating specialized bone and cartilage-growing microstructures in a single bioscaffold. It’s the surgical ideal – one integrated scaffold that can support both types of cells, to better replicate the way the body works,” explained Dr. O’Connell.
The researchers say that tests conducted with human cells using their new method have resulted in safe, non-toxic bioscaffolds. Next steps include testing out some new designs to improve cell regeneration, as well as investigating how combinations of biocompatible materials impact cell growth.
You May Also Like
3D Printing Webinar and Event Roundup: January 9, 2022
After a long break, we’re back with our first 3D Printing Webinar and Event Roundup of 2022! Things are starting back up a little slowly, with less than ten webinars...
3D Printing News Briefs, January 1st, 2022: CES 2022, Standards, Business, & More
Happy New Year! We’re starting with this week’s CES 2022 in today’s 3D Printing News Briefs, then moving on to a new AM standard and business news from Roboze and...
3D Printing Webinar and Event Roundup: December 12, 2021
As we get closer to the end of 2021, it seems like the number of webinars and events are slowing down ever so slightly. But we still have plenty to...
ICAM 2021: Keynotes on 3D Printing in Healthcare & Aerospace
At last month’s International Conference on Additive Manufacturing (ICAM) 2021 in Anaheim, California, hosted by ASTM International’s Additive Manufacturing Center of Excellence (AMCOE), a wide variety of topics were covered,...
View our broad assortment of in house and third party products.